Trial Profile
A randomized, multi-centre, observer-blind, controlled exploratory study to assess efficacy and safety of new topical formulations (MC2-01) in patients with plaque psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Drug Delivery Solutions ApS
- 15 Aug 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 26 Sep 2014 New trial record